Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.07

-3.4%

Nov 20 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Torben Noerup Nielsen who wrote (30193)	1/13/2000 11:15:00 AM
From: Mudcat	Read Replies (2) of 32384

Toben, I think it is important to find out the reasons why Panretin is/was a flop. When Lgnd first filled the pipeline with Panretin, Hank made his usual big to do about great sales. Then next quarter we saw virtually no sales of Panretin with the reason given that initial pipeline was still being used. Why has Panretin had such poor sales? I hope Lgnd has figured out why so the same mistakes are not made on Targretin. Did Targretin make Panretin obsolete? Will one of the newer drugs licensed to big pharms that Lgnd gets royalties on make Targretin obsolete? I'm more of a business person and was hoping Hank the scientist could answer these questions. But it is obvious that bringing up questions like these hurts Hank's interest in the stock so he chooses to ignore them. From a business perspective, how could people on this board not want to discuss the poor performance of one of Lgnds three approved drugs. Let's discuss the issues and not the hype of slight price moves in the stock.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next